Literature DB >> 230495

Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum.

J P Kane, D A Hardman, J C Dimpfl, J A Levy.   

Abstract

We have shown that the circulating lipoproteins of the mouse contain a potent inhibitor of infectivity of the xenotropic type C virus. This virus neutralization does not involve immunoglobulins or complement. After fractionation of the lipoproteins on the basis of particle size, flotation properties, and electrostatic charge, virus neutralizing activity is found primarily in the triglyceride-rich lipoproteins (predominantly the chylomicrons) and in the HDL(2) subfraction of the high density lipoproteins. In fasted animals, activity resides chiefly in the high density lipoproteins. Neutralization titers increase strikingly during alimentary lipemia in both the lipoproteins of the rho < 1.006 g/cm(3) fraction and the high density lipoproteins. Increased activity persists in the high density lipoproteins after the lipemia recedes. Virus neutralizing activity is completely eliminated in all fractions by antiserum against high density lipoproteins and, in the triglyceride-rich fractions, by antiserum to murine apolipoprotein B. Complete removal of lipids markedly reduces the neutralizing activity of both classes of lipoproteins. Apolipoproteins delipidated with tetramethylurea retain some activity, which is enhanced by binding to a phospholipid-stabilized triglyceride emulsion and which is abolished by proteolytic digestion. We have demonstrated in vitro transfer of activity between high density and very low density lipoproteins of the mouse. These data indicate that xenotropic virus neutralization by normal mouse serum depends upon a protein that transfers among lipoprotein particles in a fashion analogous to the C apolipoproteins of other mammalian species.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230495      PMCID: PMC411772          DOI: 10.1073/pnas.76.11.5957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins.

Authors:  J C Leong; J P Kane; O Oleszko; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

2.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 3.  Endogenous C-type viruses in normal and "abnormal" cell development.

Authors:  J A Levy
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

4.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

Review 5.  Autoimmunity and neoplasia. The possible role of C-type viruses.

Authors:  J A Levy
Journal:  Am J Clin Pathol       Date:  1974-08       Impact factor: 2.493

6.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

Authors:  R J Havel; J P Kane; M L Kashyap
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

7.  Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains.

Authors:  S E Lux; K M John; H B Brewer
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

8.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

9.  Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins.

Authors:  A M Scanu; C Edelstein
Journal:  Anal Biochem       Date:  1971-12       Impact factor: 3.365

10.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

View more
  17 in total

1.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Authors:  S T Kunitake; M R Jarvis; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.

Authors:  Masashi Suzuki; David K Pritchard; Lev Becker; Andrew N Hoofnagle; Natsuko Tanimura; Theo K Bammler; Richard P Beyer; Roger Bumgarner; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; Kensuke Miyake; John F Oram; Jay W Heinecke
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 3.  Xenotropism: the elusive viral receptor finally uncovered.

Authors:  J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

4.  Antimicrobial activity of lipoprotein particles containing apolipoprotein Al.

Authors:  N Tada; T Sakamoto; A Kagami; K Mochizuki; K Kurosaka
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

5.  Transfer of mouse anti-xenotropic virus neutralizing factor to human lipoproteins.

Authors:  J A Levy; J Dimpfl; D Hardman; J P Kane
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

6.  Neutralizing antibody response of rabbits and goats to caprine arthritis-encephalitis virus.

Authors:  P Klevjer-Anderson; T C McGuire
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice.

Authors:  J A Levy; A B Ibrahim; T Shirai; K Ohta; R Nagasawa; H Yoshida; J Estes; M Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice.

Authors:  N Green; H Hiai; J H Elder; R S Schwartz; R H Khiroya; C Y Thomas; P N Tsichlis; J M Coffin
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

9.  Genetic alterations of RNA leukemia viruses associated with the development of spontaneous thymic leukemia in AKR/J mice.

Authors:  C Y Thomas; J M Coffin
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

10.  Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses.

Authors:  M Ruta; D Kabat
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.